These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 3155536

  • 1. Species specificity of recognition by the alternative pathway of complement.
    Horstmann RD, Pangburn MK, Müller-Eberhard HJ.
    J Immunol; 1985 Feb; 134(2):1101-4. PubMed ID: 3155536
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces.
    Carreno MP, Labarre D, Maillet F, Jozefowicz M, Kazatchkine MD.
    Eur J Immunol; 1989 Nov; 19(11):2145-50. PubMed ID: 2480904
    [Abstract] [Full Text] [Related]

  • 3. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
    Johnson E, Eskeland T, Bertheussen K.
    Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
    [Abstract] [Full Text] [Related]

  • 4. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.
    Meri S, Pangburn MK.
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3982-6. PubMed ID: 1692629
    [Abstract] [Full Text] [Related]

  • 5. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system.
    Brown EJ, Joiner KA, Gaither TA, Hammer CH, Frank MM.
    J Immunol; 1983 Jul; 131(1):409-15. PubMed ID: 6223077
    [Abstract] [Full Text] [Related]

  • 6. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
    Ezzell JL, Parker CJ.
    Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
    [Abstract] [Full Text] [Related]

  • 7. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD, Fearon DT, Silbert JE, Austen KF.
    J Exp Med; 1979 Nov 01; 150(5):1202-15. PubMed ID: 501288
    [Abstract] [Full Text] [Related]

  • 8. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Immunol; 1983 Oct 01; 131(4):1930-5. PubMed ID: 6225800
    [Abstract] [Full Text] [Related]

  • 9. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    DiScipio RG.
    Biochem J; 1981 Dec 01; 199(3):485-96. PubMed ID: 6462133
    [Abstract] [Full Text] [Related]

  • 10. Reduced activity of DAF on complement enzymes bound to alternative pathway activators. Similarity with Factor H.
    Pangburn MK.
    Immunology; 1990 Dec 01; 71(4):598-600. PubMed ID: 1703989
    [Abstract] [Full Text] [Related]

  • 11. Regulation of the alternative pathway of human complement by C1q.
    Fishelson Z, Müller-Eberhard HJ.
    Mol Immunol; 1987 Sep 01; 24(9):987-93. PubMed ID: 2958692
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement.
    Pangburn MK, Pangburn KL, Koistinen V, Meri S, Sharma AK.
    J Immunol; 2000 May 01; 164(9):4742-51. PubMed ID: 10779780
    [Abstract] [Full Text] [Related]

  • 13. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H.
    Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA.
    Proc Natl Acad Sci U S A; 1988 Mar 01; 85(5):1657-61. PubMed ID: 2964038
    [Abstract] [Full Text] [Related]

  • 14. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT, Schreiber RD, Cooper NR.
    J Clin Invest; 1984 Jan 01; 73(1):160-70. PubMed ID: 6418767
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the mechanism of recognition in the complement alternative pathway using C3b-bound low molecular weight polysaccharides.
    Pangburn MK.
    J Immunol; 1989 Apr 15; 142(8):2759-65. PubMed ID: 2467938
    [Abstract] [Full Text] [Related]

  • 16. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
    Mold C, Kingzette M, Gewurz H.
    J Immunol; 1984 Aug 15; 133(2):882-5. PubMed ID: 6234363
    [Abstract] [Full Text] [Related]

  • 17. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL, Mikus LK.
    J Exp Med; 1985 Jun 01; 161(6):1414-31. PubMed ID: 2409200
    [Abstract] [Full Text] [Related]

  • 18. C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae.
    Jimenez-Lucho VE, Joiner KA, Foulds J, Frank MM, Leive L.
    J Immunol; 1987 Aug 15; 139(4):1253-9. PubMed ID: 2440949
    [Abstract] [Full Text] [Related]

  • 19. Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ, Baker PJ, Rosse WF.
    J Immunol; 1983 Nov 15; 131(5):2484-9. PubMed ID: 6226743
    [Abstract] [Full Text] [Related]

  • 20. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG, Melamed J, Arnaout MA.
    Eur J Immunol; 1983 Jun 15; 13(6):465-70. PubMed ID: 6222909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.